![Richard Glynne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Glynne
Amministratore Delegato presso
Belharra Therapeutics, Inc.
Profilo
Dr. Richard Glynne is a Chief Executive Officer at Belharra Therapeutics, Inc., a CSO at Inception Sciences, Inc. and a Venture Partner at Versant Venture Management LLC.
Dr. Glynne was previously employed as an Associate by NewCo /Ca/, an Executive Director by Novartis Institutes for Biomedical Research, Inc., an Executive Director of Genetics by Novartis AG, a VP Genetics by Phenomix Corp., and a Director Genomics by EOS Biotechnology, Inc. He received his doctorate degree from Imperial Cancer Research Fund Trading Ltd..
Posizioni attive di Richard Glynne
| Società | Posizione | Inizio |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Investitore di Private Equity | 01/01/2018 |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Corporate Officer/Principal | 01/11/2018 |
Belharra Therapeutics, Inc.
 Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company | Amministratore Delegato | 01/01/2025 |
Precedenti posizioni note di Richard Glynne
| Società | Posizione | Fine |
|---|---|---|
NewCo /Ca/
 NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food | Corporate Officer/Principal | 01/11/2018 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Investitore di Private Equity | 01/01/2018 |
| NOVARTIS AG | Investitore di Private Equity | 01/01/2015 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Investitore di Private Equity | 01/01/2004 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Corporate Officer/Principal | 01/01/2002 |
Formazione di Richard Glynne
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Imperial Cancer Research Fund Trading Ltd.
 Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
NewCo /Ca/
NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food | Distribution Services |
Belharra Therapeutics, Inc.
Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company | Commercial Services |
